100
Participants
Start Date
August 1, 2021
Primary Completion Date
July 1, 2024
Study Completion Date
July 1, 2024
Tocilizumab Asprin
"Tocilizumab alone, Asprin alone, Tocilizumab combined with Asprin. Tocilizumab, an IL6R inhibitor, injected once a month at a dose of 4mg/kg in advanced NPC patients.~Asprin,an anticoagulant, taken orally once daily at a dose of 100mg in advanced NPC patients."
Placebo
Placebo replaces tocilizumab and asprin in advanced NPC patients.
Bo You, Nantong
Affiliated Hospital of Nantong University
OTHER